ALCAMENA STEM CELL THERAPEUTICS, LLC: FDA Phase 1 Development of a Novel Nonopioid Cell and Tissue Permeable Peptide Therapeutic for Epigenetic Reprogramming of Neuropathic Pain
ALCAMENA STEM CELL THERAPEUTICS, LLC (Baltimore, Maryland): FDA Phase 1 Development of a Novel Nonopioid Cell and Tissue Permeable Peptide Therapeutic for Epigenetic Reprogramming of Neuropathic Pain. Its award of $1,500,000 is top-decile (93rd percentile of 10,712 records). Dated 61 days ago, it serves as a historical benchmark. Score 70/100. As of 2026-11-03, from NIH RePORTER (newly awarded projects).
Data as of · Compiled by Zalwin from NIH RePORTER (newly awarded projects)
award: $1,500,000 · 93th percentile of 10,712 NihBiotechGrantPulse records · 3.7x the median
Free preview: all 10 published fields of this record are shown below. Locked: 462 related MD NihBiotechGrantPulse records and the 5-column CSV export.
| Field | Value |
|---|---|
| Organization | ALCAMENA STEM CELL THERAPEUTICS, LLC |
| Location | Baltimore, MD |
| Project | FDA Phase 1 Development of a Novel Nonopioid Cell and Tissue Permeable Peptide Therapeutic for Epigenetic Reprogramming of Neuropathic Pain |
| Project number | 5R44NS145934-02 |
| Mechanism | R44 |
| Institute | National Institute of Neurological Disorders and Stroke |
| Award | $1,500,000 |
| Awarded | 2026-09-04 |
| Project period | 2025-08-07 to 2027-07-31 |
| UEI | J6DAAQH7AQL8 |
| award percentile | 93th of 10,712 (median $407,048, 3.7x median) |
| Peer records CSV (463 MD records) | 🔒 Click to unlock → |
| CRM-ready export with official source URLs | 🔒 Click to unlock → |
Watch ALCAMENA STEM CELL THERAPEUTICS, LLC
Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.
Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.
Free first: a 10-record sample of MD records
See the real columns before you buy. One confirmation email, nothing else unless you opt in.
Unlock ALCAMENA STEM CELL THERAPEUTICS + all 463 MD records (CSV)
Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Organization · State · Institute · Award · Awarded · official source URL
- Source agency: NIH RePORTER (newly awarded projects)
- Record date: 2026-09-04
- Data refreshed: 2026-11-03
- Refunds on request within 14 days
Top NihBiotechGrantPulse records (MD first): JOHNS HOPKINS UNIVERSITY · WESTAT, INC. · JOHNS HOPKINS UNIVERSITY · JOHNS HOPKINS UNIVERSITY · JOHNS HOPKINS UNIVERSITY · Browse all by state and category →
LIVE PUBLIC DATA Source: NIH RePORTER (newly awarded projects) · Last refreshed: Tue, 03 Nov 2026 18:16:24 GMT
Is this your business? Add a "Listed on Zalwin" badge to your site
Paste this snippet into your website. It links to this public record; nothing is tracked on your site.
Peer benchmark and outreach value: ALCAMENA STEM CELL THERAPEUTICS, LLC and 463 Maryland peers
- Maryland NihBiotechGrantPulse records like this one: 463
- ALCAMENA STEM CELL THERAPEUTICS, LLC's award: 93rd percentile of 10,712 records
- Timing: Low: older than 30 days
- Estimated pipeline if you contact every Maryland peer: $92,600 (peers × rate × deal size; an estimate from your assumptions, not a forecast)
70 / 100 Lab Budget Score
- Award of $1M or more.
- Research or center grant: supplies, instruments and services budget.
What is the NihBiotechGrantPulse record for ALCAMENA STEM CELL THERAPEUTICS, LLC in Baltimore, Maryland?
ALCAMENA STEM CELL THERAPEUTICS, LLC received an NIH award of $1,500,000 on 2026-09-04: FDA Phase 1 Development of a Novel Nonopioid Cell and Tissue Permeable Peptide Therapeutic for Epigenetic Reprogramming of Neuropathic Pain.
How does ALCAMENA STEM CELL THERAPEUTICS, LLC compare to other Maryland NihBiotechGrantPulse records?
This is a top-decile record: its award of $1,500,000 is 3.7x the median of $407,048 across 10,712 records. It is 61 days old; check the official source for later updates before acting. Its Lab Budget Score of 70/100 puts it among the stronger signals in this feed.
ALCAMENA STEM CELL THERAPEUTICS, LLC vs. top 3 peers
| Organization | Location | Amount | Percentile | Record date |
|---|---|---|---|---|
| ALCAMENA STEM CELL THERAPEUTICS, LLC | Baltimore, MD | 1,500,000 | 93rd | 2026-09-04 |
| JOHNS HOPKINS UNIVERSITY | BALTIMORE, MD | 1,501,239 | 93rd | 2026-09-18 |
| JOHNS HOPKINS UNIVERSITY | BALTIMORE, MD | 1,397,340 | 92nd | 2026-09-18 |
| REMEDY PLAN | GAITHERSBURG, MD | 1,181,436 | 90th | 2026-09-17 |
Related records
NihBiotechGrantPulse: records in Maryland NihBiotechGrantPulse: Small business SBIR/STTR (R41-R44, U43-U44)
More Maryland public-record feeds
eMaryland Marketplace Bids Pulse in Maryland New Trucking Company Registrations in Maryland Maryland Registered Products Pulse in Maryland FEMA Hazard Mitigation Project Tracker in Maryland Montgomery County MD HHS - Food Inspection Data from July 2024 and on Pulse in Maryland HIPAA Breach Reports (500+ Individuals) by State & Type in Maryland Newly Posted IRS Automatic Revocations of Tax Exemption in Maryland Federal Alcohol Permit Holder Directory in Maryland
How to monitor ALCAMENA STEM CELL THERAPEUTICS, LLC and peer small business sbir/sttr (r41-r44, u43-u44) records
Get new NihBiotechGrantPulse records like ALCAMENA STEM CELL THERAPEUTICS, LLC by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
Get newly funded labs in your territory
NihBiotechGrantPulse emails new awards matching your states, mechanisms and minimum award.
✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.